Claire Friedman on Considerations for Older Patients Receiving Immunotherapy

CLAIRE FRIEDMAN, MD

Tuesday, January 31, 2017

Claire Friedman, MD, Memorial Sloan Kettering Cancer Center, discusses considerations to take when planning immunotherapy treatments for older patients. There is also the possibility of combinations to consider.

When choosing an appropriate immunotherapy agent for an older patient, clinicians should discuss the different options, and their risks and benefits, with patients. Clinicians should keep several factors in mind. Not only are a patient’s lifestyle and medical history important, but so is their social support.

Discussions >>

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.